Apica Cardiovascular Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$35.1M
- Investors
-
1
Apica Cardiovascular General Information
Description
Developer of cardiovascular devices. The company develops transapical access and closure system that is designed to open and close the apex of a beating heart, in order to deliver large therapeutic devices into the inner chambers of the heart in a minimally invasive manner.
Contact Information
Website
www.apica.ieCorporate Office
- Unit 202, Business Innovation Centre
- National University of Ireland, Upper New Castle Road
- Galway
- Ireland
Corporate Office
- Unit 202, Business Innovation Centre
- National University of Ireland, Upper New Castle Road
- Galway
- Ireland
Apica Cardiovascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 02-Jul-2014 | $35.1M | Completed | Product Development | ||
| 2. Early Stage VC (Series A) | 20-Jan-2011 | Completed | Startup | |||
| 1. Seed Round | 01-Jan-2009 | Completed | Startup |
Apica Cardiovascular Patents
Apica Cardiovascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2948104-A1 | Systems and methods for percutaneous access, stabilization and closure of organs | Active | 25-Jan-2013 | ||
| EP-2948104-A4 | Systems and methods for percutaneous access, stabilization and closure of organs | Active | 25-Jan-2013 | ||
| US-10028741-B2 | Systems and methods for percutaneous access, stabilization and closure of organs | Inactive | 25-Jan-2013 | ||
| US-11116542-B2 | Systems and methods for percutaneous access, stabilization and closure of organs | Active | 25-Jan-2013 | ||
| US-20150342602-A1 | Systems and methods for percutaneous access, stabilization and closure of organs | Active | 25-Jan-2013 | A61B17/0644 |
Apica Cardiovascular Signals
Apica Cardiovascular Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enterprise Ireland | Growth/Expansion | Minority | ||
| Georgia Research Alliance | Not-For-Profit Venture Capital | Minority | ||
| Seroba Life Sciences | Venture Capital | Minority | ||
| Triventures | Venture Capital | Minority |
Apica Cardiovascular FAQs
-
When was Apica Cardiovascular founded?
Apica Cardiovascular was founded in 2009.
-
Where is Apica Cardiovascular headquartered?
Apica Cardiovascular is headquartered in Galway, Ireland.
-
What is the size of Apica Cardiovascular?
Apica Cardiovascular has 8 total employees.
-
What industry is Apica Cardiovascular in?
Apica Cardiovascular’s primary industry is Surgical Devices.
-
Is Apica Cardiovascular a private or public company?
Apica Cardiovascular is a Private company.
-
What is the current valuation of Apica Cardiovascular?
The current valuation of Apica Cardiovascular is .
-
What is Apica Cardiovascular’s current revenue?
The current revenue for Apica Cardiovascular is .
-
How much funding has Apica Cardiovascular raised over time?
Apica Cardiovascular has raised $4.95M.
-
Who are Apica Cardiovascular’s investors?
Enterprise Ireland, Georgia Research Alliance, Seroba Life Sciences, and Triventures have invested in Apica Cardiovascular.
-
When was Apica Cardiovascular acquired?
Apica Cardiovascular was acquired on 02-Jul-2014.
-
Who acquired Apica Cardiovascular?
Apica Cardiovascular was acquired by Thoratec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process